Safety And Tolerability Of Outpatient Transition Of Parenteral And Inhaled Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension

被引:0
|
作者
Khan, A. A. [1 ]
Ackerbauer, K. [1 ]
Tandon, R. [1 ]
机构
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3970
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Safety And Tolerability Of Transitioning From Parenteral Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    White, R. J.
    Chakinala, M. M.
    Mathier, M.
    Howell, M.
    Laliberte, K.
    Feldman, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [2] Safety And Tolerability Of Transitioning From Parenteral Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    White, R. J.
    Chakinala, M.
    Rischard, F.
    Howell, M.
    Laliberte, K.
    Feldman, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [3] Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension
    Preston, Ioana R.
    Feldman, Jeremy
    White, James
    Franco, Veronica
    Ishizawar, David
    Burger, Charles
    Waxman, Aaron B.
    Hill, Nicholas S.
    [J]. PULMONARY CIRCULATION, 2014, 4 (03) : 456 - 461
  • [4] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    [J]. PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [5] Transition to Oral Treprostinil from Parenteral or Inhaled Treprostinil or as Add-On Therapy in Pediatric Subjects with Pulmonary Arterial Hypertension
    Ivy, D.
    Feinstein, J.
    Yung, D.
    Mullen, M.
    Kirkpatrick, E.
    Hirsch, R.
    Austin, E. D.
    Fineman, J.
    Doran, A.
    Solum, D.
    Deng, C.
    Hopper, R. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Transition from parenteral to oral treprostinil in pulmonary arterial hypertension
    Chakinala, Murali M.
    Feldman, Jeremy P.
    Rischard, Franz
    Mathier, Michael
    Broderick, Meredith
    Leedom, Nicole
    Laliberte, Kevin
    White, R. James
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (02): : 193 - 201
  • [7] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Kimmig, Lucas M.
    Liao, Chuanhong
    Bag, Remzi
    [J]. LUNG, 2020, 198 (01) : 53 - 58
  • [8] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Lucas M. Kimmig
    Chuanhong Liao
    Remzi Bag
    [J]. Lung, 2020, 198 : 53 - 58
  • [9] INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
    Hill, Nicholas S.
    Feldman, Jeremy P.
    Sahay, Sandeep
    Benza, Raymond L.
    Preston, Ioana R.
    Badesch, David
    Frantz, Robert P.
    Patel, Savan
    Galloway, Ashley
    Bull, Todd M.
    [J]. PULMONARY CIRCULATION, 2022, 12 (03)
  • [10] Transition From Subcutaneous or Inhaled Treprostinil to Oral Treprostinil at Home in Patients With Pulmonary Arterial Hypertension: A Retrospective Case Series
    Ackerbauer, Kimberly A.
    Tandon, Rajive
    [J]. JOURNAL OF PHARMACY PRACTICE, 2018, 31 (02) : 163 - 166